Mid Atlantic Chapter of AACE 15th Annual Meeting

September 22, 2017 to September 23, 2017

The Mid Atlantic Chapter of AACE program committee has worked very hard to provide a relevant activity for the practicing clinical physician and other healthcare providers seeking education with an emphasis in endocrine disease.

This program has been planned to provide pertinent scientific and clinical information to help you achieve the best solutions in the diagnosis and therapeutic management of patients presenting with endocrine disease. Attendees will obtain updates in not only common and uncommon endocrine disorders, but also newer treatment modalities.

Providing exceptional patient care requires continuing high quality education. The American Association of Clinical Endocrinologists (AACE) was founded in 1991 by a visionary group of leaders to serve as the active voice for clinical endocrinologists. The impetus behind AACE's efforts has always been quality and cost-effective patient care for those with endocrine diseases and disorders. We hope that you will find this program of great value to you in your practice.

Target Audience

Endocrinologists, other physicians, advanced practice clinicians, and allied health professionals who are interested in the treatment of endocrine disease states that reside or practice in Delaware, Maryland, Virginia and Washington DC.

Learning Objectives

  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
  2. Review mechanism of action of SGLT-2 inhibitors
  3. Summarize outcome data
  4. Create a paradigm for use in clinical practice
  5. Identify the risk of recurrent Cushing's disease
  6. Describe the best diagnostic tests for recurrence of Cushing's disease
  7. Select among treatment options for Cushing's syndrome based on the pros and cons of each
  8. Describe clinical presentation of patients with post-bariatric hypoglycemia
  9. Understand evaluation and treatment approaches for post-bariatric hypoglycemia
  10. Understand the pathophysiology of post-bariatric hypoglycemia
  11. Interpret lab values when testing for pheochromocytoma/paraganglioma
  12. Describe perioperative blockade regimens
  13. Realize the importance of clinical genetic testing for patients with pheochromocytoma/paraganglioma
  14. Discuss the pathophysiology of renal related bone disease
  15. Discuss current guidelines for management of calcium, phosphorus, and parathyroid hormone
  16. Discuss options for treatment for low bone density in renal disease
  17. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
Additional information
Available for MOC Points?: 
No
Practice Area: 
Diabetes
Hypoglycemia
Obesity
General Endo
Course summary
Available credit: 
  • 4.50 AMA
  • 4.50 Attendance
Course opens: 
09/22/2017
Course expires: 
09/23/2018
Event starts: 
09/22/2017 - 7:30pm
Event ends: 
09/23/2017 - 3:30pm
Cost:
$0.00

Friday, September 22, 2017

7:30 - 9:00 PMWelcome Reception
9:00 - 10:00 PMFellows Programming & Networking

Saturday, September 23, 2017

7:00 - 8:00 AMRegistration and Continental Breakfast 
8:00 - 8:05 AMOpening Remarks
Michael Irwig, MD, FACE; Mid Atlantic AACE President
8:05 - 8:20 AMPre Meeting Assessment
Objectives:
  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
8:20 - 9:00 AMUse of SGLT-2 Inhibitors in Clinical Practice
Anne Peters, MD
Objectives:
  1. Review mechanism of action of SGLT-2 inhibitors
  2. Summarize outcome data
  3. Create a paradigm for use in clinical practice
9:00 - 9:10 AMQuestion & Answer
9:10 - 9:50 AMRecurrent Cushing’s Disease- What are the options?
Beverly Biller, MD
Objectives:
  1. Identify the risk of recurrent Cushing's disease
  2. Describe the best diagnostic tests for recurrence of Cushing's disease
  3. Select among treatment options for Cushing's syndrome based on the pros and cons of each
9:50 - 10:00 AMQuestion & Answer
10:00 - 10:30 AMBreak
10:30 - 11:10 AMHypoglycemia after Bariatric Surgery: Diagnostic and therapeutic strategies
Mary Elizabeth Patti, MD
Objectives:
  1. 1. Describe clinical presentation of patients with post-bariatric hypoglycemia
  2. Understand evaluation and treatment approaches for post-bariatric hypoglycemia
  3. Understand the pathophysiology of post-bariatric hypoglycemia
11:10 - 11:20 AMQuestion & Answer
11:20 - 12:00 PMPheochromocytoma/Paraganglioma: A zebra among horses
Lauren Fishbein, MD, PhD
Objectives:
  1. Interpret lab values when testing for pheochromocytoma/paraganglioma
  2. Describe perioperative blockade regimens
  3. Realize the importance of clinical genetic testing for patients with pheochromocytoma/paraganglioma
12:00 - 12:10 PMQuestion & Answer
12:10 - 12:40 PMBusiness Meeting
12:40 - 1:40 PMLunch & Fellows/Faculty Roundtable
1:40 - 2:20 PMLipids: Guidelines and best treatment options
Michael Miller, MD, FACC, FAHA
Objectives:
  1. 1. Appreciate the latest tools for management of dyslipidemia
  2. 2. Understand the pathophysiology related to TRL and CVD
  3. 3. Select the most optimal therapies based on RCT data
2:20 - 2:30 PMQuestion & Answer
2:30 - 3:10 PMMetabolic Bone Disease Related to Chronic Kidney Disease
Deborah Sellmeyer, MD
Objectives:
  1. Discuss the pathophysiology of renal related bone disease
  2. Discuss current guidelines for management of calcium, phosphorus, and parathyroid hormone
  3. Discuss options for treatment for low bone density in renal disease
3:10 - 3:20 PMQuestion & Answer
3:20 - 3:30 PMPost-Meeting Assessment
Objectives:
  1. 1. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
3:30 PMAdjournment
Hyattsville, MD
United States

Beverly MK Biller, MD, FACP
Professor of Medicine, Harvard Medical School
Neuroendocrine Unit, Massachusetts General Hospital
Boston, MA

Lauren Fishbein, MD, PhD, MTR
Assistant Professor of Medicine
Division of Endocrinology, Metabolism and Diabetes
Division of Biomedical Informatics and Personalized Medicine
University of Colorado School of Medicine
Aurora, CO

Michael Miller, MD, FACC, FAHA
Professor of Cardiovascular Medicine, Epidemiology & Public Health
University of Maryland School of Medicine
Staff Physician, Baltimore VAMC
Director, Center for Preventive Cardiology
University of Maryland Medical Center
Baltimore, Maryland

Mary Elizabeth Patti, MD
Investigator and Adult Endocrinologist, Joslin Diabetes Center
Associate Professor of Medicine, Harvard Medical School
Boston, MA

Anne Peters, MD
Professor, Keck School of Medicine of the University of Southern California
Los Angeles, CA

Deborah E. Sellmeyer, MD
Member, Miller-Coulson Academy of Clinical Excellence
Associate Professor of Medicine
Director, Metabolic Bone Center
The Johns Hopkins Bayview Medical Center
Baltimore, MD

* Indicates both a member of the Program Committee and faculty.

The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 4.50 AMA
  • 4.50 Attendance

Accreditation Period

Course opens: 
09/22/2017
Course expires: 
09/23/2018

Price

Cost:
$0.00
Please login or register to take this course.